Comparative efficacy and safety of fractional CO₂ laser versus fractional erbium-doped yttrium aluminum garnet lasers for treating enlarged facial pores
Rawal Medical Journal · 2026 · 51 (4) · 1024
DOI: 10.5455/rmj.20260820084704 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rawal Medical Journal, 2026. Verfasst von Dindar Qurtas.
Abstract (Originalsprache)
Objective
To compare the efficacy, safety, and patient-reported outcomes of fractional carbon dioxide (CO₂) versus fractional erbium-doped yttrium aluminium garnet (Er:YAG) lasers for treating enlarged facial pores. Methodology: This prospective analysis included 76 patients (38 in each group) who received three monthly sessions of either fractional CO₂ or Er:YAG laser. Outcomes measured mean pore size reduction via imaging analysis, quartile-scale improvement, patient satisfaction, and adverse effects. Statistical comparisons used t-tests and chi-square tests (p≤0.05).
Results
Both lasers significantly reduced pore size from baseline. CO₂ laser achieved a substantially greater mean reduction (~62%) compared to Er:YAG (~16%) p
Zitieren
APA
Qurtas, D. (2026). Comparative efficacy and safety of fractional CO₂ laser versus fractional erbium-doped yttrium aluminum garnet lasers for treating enlarged facial pores. Rawal Medical Journal, 51(4), 1024. https://doi.org/10.5455/rmj.20260820084704
Vancouver
Qurtas D. Comparative efficacy and safety of fractional CO₂ laser versus fractional erbium-doped yttrium aluminum garnet lasers for treating enlarged facial pores. Rawal Medical Journal. 2026;51(4):1024. doi:10.5455/rmj.20260820084704
BibTeX
@article{Qurtas2026,
author = {Qurtas, Dindar},
title = {Comparative efficacy and safety of fractional CO₂ laser versus fractional erbium-doped yttrium aluminum garnet lasers for treating enlarged facial pores},
journal = {Rawal Medical Journal},
year = {2026},
volume = {51},
number = {4},
pages = {1024},
doi = {10.5455/rmj.20260820084704}
}
EUVIMED